1. Home
  2. APLT vs CMTL Comparison

APLT vs CMTL Comparison

Compare APLT & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • CMTL
  • Stock Information
  • Founded
  • APLT 2016
  • CMTL 1967
  • Country
  • APLT United States
  • CMTL United States
  • Employees
  • APLT N/A
  • CMTL N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • CMTL Radio And Television Broadcasting And Communications Equipment
  • Sector
  • APLT Health Care
  • CMTL Technology
  • Exchange
  • APLT Nasdaq
  • CMTL Nasdaq
  • Market Cap
  • APLT 37.5M
  • CMTL 41.7M
  • IPO Year
  • APLT 2019
  • CMTL N/A
  • Fundamental
  • Price
  • APLT $0.35
  • CMTL $2.34
  • Analyst Decision
  • APLT Buy
  • CMTL Strong Buy
  • Analyst Count
  • APLT 7
  • CMTL 1
  • Target Price
  • APLT $6.10
  • CMTL $6.00
  • AVG Volume (30 Days)
  • APLT 1.4M
  • CMTL 356.3K
  • Earning Date
  • APLT 08-06-2025
  • CMTL 06-09-2025
  • Dividend Yield
  • APLT N/A
  • CMTL N/A
  • EPS Growth
  • APLT N/A
  • CMTL N/A
  • EPS
  • APLT N/A
  • CMTL N/A
  • Revenue
  • APLT $265,000.00
  • CMTL $495,352,000.00
  • Revenue This Year
  • APLT $1,768.13
  • CMTL N/A
  • Revenue Next Year
  • APLT $292.85
  • CMTL $4.14
  • P/E Ratio
  • APLT N/A
  • CMTL N/A
  • Revenue Growth
  • APLT N/A
  • CMTL N/A
  • 52 Week Low
  • APLT $0.30
  • CMTL $1.19
  • 52 Week High
  • APLT $10.62
  • CMTL $5.16
  • Technical
  • Relative Strength Index (RSI)
  • APLT 42.17
  • CMTL 55.52
  • Support Level
  • APLT $0.34
  • CMTL $1.90
  • Resistance Level
  • APLT $0.38
  • CMTL $2.65
  • Average True Range (ATR)
  • APLT 0.02
  • CMTL 0.22
  • MACD
  • APLT -0.00
  • CMTL -0.04
  • Stochastic Oscillator
  • APLT 7.14
  • CMTL 48.94

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

Share on Social Networks: